Australia's Clarity Pharmaceuticals rises on deal with US co
16/10/2025 05:59
** Clarity Pharmaceuticals CU6.AX jumps as much as ~15% to A$5.25; marks biggest intraday pct rise since October 3 ** Clinical radio-pharmaceutical co signs copper-67 supply agreement with California-based Nusano ** Nusano to supply therapeutic isotope for co's clinical trials, commercial use ** YTD, CU6 gains 23.7% (Reporting by Anjali Singh in Bengaluru) ((anjali.singh2@thomsonreuters.com;))
Recent news on Clarity Pharmaceuticals
See all newsBrief: Clarity Pharmaceuticals Signs Commercial Manufacturing Agreement
Brief: Clarity Signs A Large-Scale Manufacturing Supply Agreement For Copper-64 With Theragenics
Brief: Clarity Pharmaceuticals Signs A Large-Scale Manufacturing Supply Agreement
Australia's Clarity Pharmaceuticals rises on bagging cancer detection agent supply
Australia's Clarity Pharma surges as US FDA approves trial